Gene · 574452
Papers2,094
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,094
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biological functions and clinical implications of the CMPK2 across multisystemic diseases. | Cell Biosci | 2025 | 40867000 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in the Regulation of Oncogenic Pathways in Breast and Gynaecological Cancers. | Noncoding RNA | 2025 | 40863727 | PubTator, text mining | PubMed |
| Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy. | Diabetes Metab Res Rev | 2025 | 40831067 | PubTator, text mining | PubMed |
| ConvNTC: convolutional neural tensor completion for detecting "A-A-B" type biological triplets. | Brief Bioinform | 2025 | 40748325 | PubTator, text mining | PubMed |
| Diagnostic and therapeutic impact of miR-142, miR-146a, and miR-155 on cutaneous T-cell lymphoma. | Eur J Dermatol | 2025 | 40742055 | PubTator, text mining | PubMed |
| Regulatory roles of non-coding RNAs in programmed cell death pathways and drug resistance in gastrointestinal stromal tumors. | Clin Exp Med | 2025 | 40347390 | PubTator, text mining | PubMed |
| The role of LncRNA-MANCR induced by HIF-1α drive the malignant progression of pancreatic cancer by targeting miRNA-494/SIRT1 signaling axis under hypoxic conditions. | Cancer Gene Ther | 2025 | 40195439 | PubTator, text mining | PubMed |
| MicroRNAs in the Diagnosis of Digestive Diseases: A Comprehensive Review. | J Clin Med | 2025 | 40142862 | PubTator, text mining | PubMed |
| Exploring miR-577 and miR-494-3p as Emerging Biomarkers in Sepsis-Associated Acute Kidney Injury: Diagnostic and Prognostic Perspectives. | Microbiol Immunol | 2025 | 40089974 | PubTator, text mining | PubMed |
| Retraction: Overexpression of long non-coding RNA SBF2-AS1 promotes cell progression in esophageal squamous cell carcinoma (ESCC) by repressing miR-494 to up-regulate PFN2 expression. | Biol Open | 2025 | 40067026 | PubTator, text mining | PubMed |
| Inhibition of hemangioma development by regulating the VEGF/VEGFR autocrine loop via the miR-494/PTEN pathway. | Discov Oncol | 2025 | 39937301 | PubTator, text mining | PubMed |
| MicroRNAs and hypospadias: A systematic review. | Med Int (Lond) | 2025 | 39624466 | PubTator, text mining | PubMed |
| Exosomal miR-494 Regulates the Biological Behavior of Trophoblasts by Targeting mTOR in Unexplained Recurrent Spontaneous Abortion. | Mol Biotechnol | 2025 | 39402429 | PubTator, text mining | PubMed |
| First Transcriptome Analysis of Hepatoblastoma in Brazil: Unraveling the Pivotal Role of Noncoding RNAs and Metabolic Pathways. | Biochem Genet | 2025 | 38649558 | PubTator, text mining | PubMed |
| Effects of Exosome miR-494 on Proliferation, Migration, and Invasion of Trophoblastic Cells by Regulating the PTEN/PI3K/Akt Pathway. | Ann Clin Lab Sci | 2024 | 39855746 | PubTator, text mining | PubMed |
| Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer. | Int J Mol Sci | 2024 | 39769441 | PubTator, text mining | PubMed |
| MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective Analysis. | Int J Mol Sci | 2024 | 39684593 | PubTator, text mining | PubMed |
| The implication of TET1, miR-200, and miR-494 expression with tumor formation in colorectal cancer: through targeting Wnt signaling. | Mol Biol Rep | 2024 | 39495308 | PubTator, text mining | PubMed |
| The Association Between Anti-Neoplastic Effects of Curcumin and Urogenital Cancers: A Systematic Review. | Biomed Res Int | 2024 | 39445208 | PubTator, text mining | PubMed |
| MicroRNA expression signature in gastrointestinal stromal tumour & their molecular & histological features. | Indian J Med Res | 2024 | 39382501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/574452/papers?page=2